Silvia McColl Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Sell
3,944
-35
-0.9% -$8.16K 0.6% 41
2026
Q1
$973K Sell
3,979
-77
-2% -$17.9K 0.64% 40
2025
Q4
$839K Sell
4,056
-200
-5% -$39.5K 0.56% 43
2025
Q3
$789K Sell
4,256
-134
-3% -$23K 0.53% 46
2025
Q2
$671K Sell
4,390
-435
-9% -$66.9K 0.49% 48
2025
Q1
$800K Sell
4,825
-74
-2% -$11.6K 0.61% 40
2024
Q4
$708K Sell
4,899
-93
-2% -$14.4K 0.53% 46
2024
Q3
$809K Sell
4,992
-565
-10% -$90K 0.61% 43
2024
Q2
$812K Sell
5,557
-40
-0.7% -$5.95K 0.67% 38
2024
Q1
$841K Sell
5,597
-515
-8% -$82K 0.72% 35
2023
Q4
$958K Buy
6,112
+214
+4% +$32.8K 0.86% 29
2023
Q3
$919K Sell
5,898
-1,378
-19% -$227K 0.92% 27
2023
Q2
$1.2M Buy
7,276
+181
+3% +$29.2K 1.12% 19
2023
Q1
$1.1M Hold
7,095
1.09% 21
2022
Q4
$1.25M Buy
+7,095
New +$1.23M 1.23% 21

Other funds holding JNJ

Silvia McColl Wealth Management's JNJ Position: Q2 2026 in Review

Silvia McColl Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.88% in Q2 2026, selling an estimated $8.16K and leaving 3,944 shares worth $1M. The position accounts for 0.6% of the portfolio, ranked #41.

Silvia McColl Wealth Management first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.25M in Q4 2022. 1,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Silvia McColl Wealth Management held 3,944 shares of Johnson & Johnson worth $1M as of Q2 2026.
  • Silvia McColl Wealth Management sold 35 Johnson & Johnson shares in Q2 2026, an estimated $8.16K.
  • Johnson & Johnson made up 0.6% of Silvia McColl Wealth Management's portfolio in Q2 2026, its #41 holding.
  • Silvia McColl Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Silvia McColl Wealth Management's Johnson & Johnson position peaked at $1.25M in Q4 2022.
  • 1,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Silvia McColl Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.